Luteal phase HCG support for unexplained recurrent pregnancy loss – a low hanging fruit? Chelsea Fox, Denise Azores-Gococo, Linda Swart, Kristin Holoch, Ricardo F. Savaris, Creighton E. Likes, Paul B. Miller, David A. Forstein, Bruce A. Lessey Reproductive BioMedicine Online Volume 34, Issue 3, Pages 319-324 (March 2017) DOI: 10.1016/j.rbmo.2016.11.016 Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions
Figure 1 Flow chart depicting the number of recurrent pregnancy loss patients in each group and the number of outcomes according to the monitored cycles. Reproductive BioMedicine Online 2017 34, 319-324DOI: (10.1016/j.rbmo.2016.11.016) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions
Figure 2 A Log-rank Mantel-Cox survival curve showing percentage of monitored cycles of women with unexplained recurrent pregnancy loss that resulted in miscarriage. B Gehan-Breslow-Wilcoxon test survival curve of monitored cycles of women with unexplained recurrent pregnancy loss patients that resulted in pregnancy. Reproductive BioMedicine Online 2017 34, 319-324DOI: (10.1016/j.rbmo.2016.11.016) Copyright © 2016 Reproductive Healthcare Ltd. Terms and Conditions